PROCEPT BioRobotics Corporation PRCT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$102.47M-13.6% | -$95.57M-4.5% | -$84.58M+15.5% | -$84.15M+18.9% | -$90.19M+12.7% | ||
| $6.65M+20.4% | $6.39M+22.1% | $6.13M+20.3% | $5.84M+21.1% | $5.53M+31.6% | ||
| $50.57M+41.7% | $47.6M+49.5% | $45.85M+65.3% | $39.87M+62.4% | $35.69M+64.7% | ||
| —— | —— | $1.81M+297% | $1.74M— | $1.17M— | ||
| —— | —— | —— | —— | $24.33M-31.4% | ||
| $15.81M-28.2% | $15.07M-12.6% | $16.87M— | $24.02M— | $22.03M— | ||
| —— | —— | —— | —— | —— | ||
| $511K-73.9% | $1.1M-65.7% | $2.67M— | $2.23M— | $1.96M— | ||
| —— | —— | —— | $1.9M+267% | $855K+552% | ||
| $3.71M-0.9% | $3.32M-10.7% | $2.79M-5.4% | $3.09M+58.1% | $3.75M+53.9% | ||
| —— | -$157K— | -$117.75K— | -$78.5K— | -$39.25K— | ||
| $3.46M-1.3% | $1.59M-65.8% | $2.91M-47.7% | $1.41M— | $3.51M— | ||
| -$70.13M+16.4% | -$48.99M+50.6% | -$71.05M+22.4% | -$83.21M+9.3% | -$83.91M+19.6% | ||
| $10.43M+143% | $9.36M+112% | $8.68M-27.4% | $6.06M-65.4% | $4.3M-80.3% | ||
| -$10.43M-143% | -$9.36M-112% | -$8.68M+27.4% | -$6.06M+65.4% | -$4.3M+80.3% | ||
| -$1.08M-101% | $0-100% | $167.75M— | $160.91M-3.9% | $163.21M-1.5% | ||
| $10.12M-94.3% | $11.19M-93.8% | $177.28M+1,322% | $177.92M+2.9% | $178.84M+5.2% | ||
| -$116K— | -$74K— | -$33K— | -$23K— | —— | ||
| -$70.57M-178% | -$47.22M-162% | $97.52M— | $88.62M— | $90.63M— | ||
| $3.38M-12.3% | $3.46M-12.8% | $3.56M-12.2% | $3.69M-8.4% | $3.85M-2.2% | ||
| $3.46M-1.3% | $1.59M-65.8% | $2.91M-47.7% | $1.41M— | $3.51M— | ||
| $166K+30.7% | $142K+6.0% | $128K-3.0% | $120K-7.7% | $127K-1.6% | ||
| $2.93M+57.8% | $2.9M+69.9% | $3.28M+262% | $2.63M+156% | $1.86M+67.5% | ||
| $511K-73.9% | $1.1M-65.7% | $2.67M— | $2.23M— | $1.96M— | ||
| $461K-78.9% | $566K-69.9% | $1.17M-9.0% | $1.47M-1.3% | $2.18M+184% | ||
| $540K+30.4% | $508K+32.6% | $477K— | $446K— | $414K— | ||
| —— | —— | $1.81M+297% | $1.74M— | $1.17M— | ||
| —— | —— | —— | —— | —— | ||
| -$116K— | -$74K— | -$33K— | -$23K— | —— | ||
| —— | —— | —— | —— | —— | ||
| $3.71M-0.9% | $3.32M-10.7% | $2.79M-5.4% | $3.09M+58.1% | $3.75M+53.9% | ||
| -$80.57M+8.7% | -$58.34M+43.7% | -$79.73M+23.0% | -$89.27M+18.3% | -$88.21M+30.1% | ||
| -$80.57M+8.7% | -$58.34M+43.7% | -$79.73M+23.0% | -$89.27M+18.3% | -$88.21M+30.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does PROCEPT BioRobotics Corporation generate?
- PROCEPT BioRobotics Corporation (PRCT) generated -$70.1M in operating cash flow over the trailing twelve months.
- What is PROCEPT BioRobotics Corporation's free cash flow?
- After $10.4M of capital expenditures, PROCEPT BioRobotics Corporation's free cash flow was -$80.6M over the trailing twelve months, up 8.7% year over year.
- Where does PROCEPT BioRobotics Corporation's cash flow data come from?
- Every line is extracted from PROCEPT BioRobotics Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
